Y. Yang

发表

Interleukin-12 inhibits graft-versus-host disease through an Fas-mediated mechanism associated with alterations in donor T-cell activation and expansion.

G. Szot, M. Sykes, B. Dey, 1998, Blood.

Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.

M. Sykes, Yong-Guang Yang, B. Dey, 1998, The Journal of clinical investigation.

The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.

D. Dombkowski, M. Sykes, A. Shimizu, 1999, Transplantation.

Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.

M. Sykes, Y. Yang, D. Pearson, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Porcine stem cell engraftment and seeding of murine thymus with class II+ cells in mice expressing porcine cytokines: toward tolerance induction across discordant xenogeneic barriers.

D. Sachs, M. Sykes, Y. Zhou, 2000, Transplantation.

Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection.

H. Ohdan, M. Sykes, A. Shimizu, 1999, The Journal of clinical investigation.

The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.

M. Sykes, Y. Yang, Megan Sykes, 1999, Leukemia & lymphoma.

Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.

G. Szot, M. Sykes, A. Shimizu, 1997, Blood.

Role of antibody-independent complement activation in rejection of porcine bone marrow cells in mice.

M. Sykes, Y. Zhou, Y. Yang, 2000, Transplantation.

Hematopoietic chimerism and tolerance of T cells, B cells, and NK cells.

H. Ohdan, M. Sykes, T. Wekerle, 1998, Transplantation proceedings.

In vivo T-cell depletion enhances production of anti-GALalpha1,3GAL natural antibodies in alpha1,3-galactosyltransferase-deficient mice.

H. Ohdan, M. Sykes, A. Thall, 2000, Transplantation.

Interleukin-12 prevents severe acute graft-versus-host disease (GVHD) and GVHD-associated immune dysfunction in a fully major histocompatibility complex haplotype-mismatched murine bone marrow transplantation model.

M. Sykes, B. Dey, Y. Yang, 1997, Transplantation.

Hematopoietic stem cell quiescence maintained by p21cip1/waf1.

D. Scadden, D. Dombkowski, T. Cheng, 2000, Science.

B-cell reconstitution and xenoreactive anti-pig natural antibody production in severe combined immunodeficient mice reconstituted with immunocompetent B cells from varying sources.

M. Sykes, R. Barth, E. Degoma, 1998, Transplantation.

The role of interleukin-12 and interferon-gamma in GVHD and GVL.

Y. Yang, 2000, Cytokines, cellular & molecular therapy.

T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.

H. Ohdan, M. Sykes, H. Kitamura, 2001, Transplantation.

Enhanced porcine hematopoiesis in mice receiving donor-specific interleukin-3.

M. Sykes, R. Monroy, Y. Yang, 1996, Transplantation proceedings.